UA96574C2 - Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции - Google Patents

Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции

Info

Publication number
UA96574C2
UA96574C2 UAA200800220A UAA200800220A UA96574C2 UA 96574 C2 UA96574 C2 UA 96574C2 UA A200800220 A UAA200800220 A UA A200800220A UA A200800220 A UAA200800220 A UA A200800220A UA 96574 C2 UA96574 C2 UA 96574C2
Authority
UA
Ukraine
Prior art keywords
ivabradine
treatment
endothelial dysfunction
medicaments intended
obtaining medicaments
Prior art date
Application number
UAA200800220A
Other languages
English (en)
Ukrainian (uk)
Inventor
Видаль Бенатар
Ги Леребур-Пижоньер
Жан-Клод Тардиф
Эрик Торин
Эрик Реоме
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA96574C2 publication Critical patent/UA96574C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Изобретение касается использования ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции.
UAA200800220A 2007-01-11 2008-01-04 Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции UA96574C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700189A FR2911279B1 (fr) 2007-01-11 2007-01-11 Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale

Publications (1)

Publication Number Publication Date
UA96574C2 true UA96574C2 (ru) 2011-11-25

Family

ID=38123876

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200800220A UA96574C2 (ru) 2007-01-11 2008-01-04 Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции

Country Status (21)

Country Link
US (2) US20080200450A1 (ru)
EP (1) EP1944031A1 (ru)
JP (1) JP2008169213A (ru)
KR (2) KR20080066613A (ru)
CN (1) CN101480398B (ru)
AR (1) AR064832A1 (ru)
AU (1) AU2008200123B2 (ru)
BR (1) BRPI0800001A2 (ru)
CA (1) CA2617363C (ru)
EA (1) EA015398B1 (ru)
FR (1) FR2911279B1 (ru)
GE (1) GEP20115158B (ru)
HK (1) HK1130686A1 (ru)
MA (1) MA29720B1 (ru)
MX (1) MX2008000023A (ru)
MY (1) MY148650A (ru)
NZ (1) NZ564997A (ru)
SG (1) SG144832A1 (ru)
UA (1) UA96574C2 (ru)
WO (1) WO2008099091A2 (ru)
ZA (1) ZA200800358B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2938194B1 (fr) * 2008-11-07 2012-08-31 Servier Lab Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
GB201312386D0 (en) * 2013-07-10 2013-08-21 Isis Innovation Pharmaceutical compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
MXPA02010090A (es) * 2000-04-12 2003-02-12 Novartis Ag Combinacion de al menos dos compuestos seleccionados de los grupos de un antagonista del receptor at-1 o un inhibidor ace o un inhibidor de la hmg-co-a reductasa.
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
CA2617363C (fr) 2012-12-04
CN101480398A (zh) 2009-07-15
EA200800022A3 (ru) 2008-12-30
US20080200450A1 (en) 2008-08-21
HK1130686A1 (en) 2010-01-08
EA015398B1 (ru) 2011-08-30
BRPI0800001A2 (pt) 2010-02-23
US20110288072A1 (en) 2011-11-24
NZ564997A (en) 2009-09-25
KR20100112540A (ko) 2010-10-19
MA29720B1 (fr) 2008-09-01
MY148650A (en) 2013-05-15
EP1944031A1 (fr) 2008-07-16
FR2911279B1 (fr) 2009-03-06
SG144832A1 (en) 2008-08-28
GEP20115158B (en) 2011-02-10
CN101480398B (zh) 2011-07-27
WO2008099091A2 (fr) 2008-08-21
WO2008099091A3 (fr) 2008-10-02
EA200800022A2 (ru) 2008-08-29
KR101359936B1 (ko) 2014-02-10
AU2008200123B2 (en) 2012-08-16
MX2008000023A (es) 2009-02-23
FR2911279A1 (fr) 2008-07-18
KR20080066613A (ko) 2008-07-16
JP2008169213A (ja) 2008-07-24
AU2008200123A1 (en) 2008-07-31
AR064832A1 (es) 2009-04-29
ZA200800358B (en) 2008-11-26
CA2617363A1 (fr) 2008-07-11

Similar Documents

Publication Publication Date Title
HK1220631A1 (zh) 用於遞送治療劑的陰離子核心組合物以及製備和使用所述組合物的方法
FR2932478B1 (fr) Composes utiles pour le traitement des cancers.
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
EA201171367A1 (ru) Винилиндазолильные соединения
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
GB201017345D0 (en) Receptor antagonists
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
HK1165813A1 (en) Anti cxcr4 antibodies for the treatment of hiv hiv cxcr4
IL213920A0 (en) 3,3'-spiroindolinone derivatives as anticancer agents
GB0921075D0 (en) Novel combination of the therapeutic agents
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2009011346A (es) Tapentadol para tratamiento de dolor con artritis.
EP2411042A4 (en) Tissue kallikrein for the treatment of pancreatic cell dysfunction
UA103996C2 (en) Ivabradine hydrobromide
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
UA103468C2 (ru) Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3
EP2576575A4 (en) PROSTAGLANDIN-BISPHOSPHONATE CONJUGATE COMPOUNDS, THEIR METHODS OF MANUFACTURE AND USES THEREOF
PH12017500270A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
UA96574C2 (ru) Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции
IL218286A0 (en) Targeting pax2 for the treatment of breast canecr
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
MX2010003056A (es) Polimorfos de valomaciclovir.
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof